BRAF |
Serine/threonine-protein kinase B-raf (rapidly accelerated fibrosarcoma) |
cfDNA |
Cell-free DNA |
CK-18 |
Cytokeratin 18 |
CT |
Computer tomography |
ctDNA |
Circulating tumor DNA |
CTx |
Platinum-based chemotherapy |
ECOG |
Eastern Cooperative Oncology Performance Status Scale |
EGFR |
Epidermal growth factor receptor |
EML4-ALK |
Echinoderm microtubule associated protein-like 4-anaplastic lymphoma kinase |
GSH |
Glutathione |
M30 |
Caspase-cleaved cytokeratin 18 |
M65 |
Full-length cytokeratin 18 |
miRNA |
MicroRNA |
MRI |
Magnetic resonance imaging |
NOS |
Non other specified |
NSCLC |
Non-small cell lung cancer |
oxGSH |
Oxidized glutathione |
PD |
Progressive disease |
PDL1 |
Programmed death ligand 1 |
PR |
Partial remission |
RECIST-1.1 |
Response Evaluation Criteria in Solid Tumors, version 1.1 |
SD |
Stable disease |
TKI |
Tyrosine-kinase-inhibitor |